Umbilical Cord Blood Collection and Processing for Hypoplastic Left Heart Syndrome Patients

NACompletedINTERVENTIONAL
Enrollment

464

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

November 12, 2024

Study Completion Date

November 12, 2024

Conditions
Hypoplastic Left Heart Syndrome (HLHS)
Interventions
OTHER

Collection of umbilical cord blood

Cord blood will be processed in the temperate state it was collected to produce a pure, stem cell product identifiable to patients with Hypoplastic Left Heart Syndrome, and will be stored at a frozen state for their potential, future use in a clinical trial.

Trial Locations (2)

19104

Children's Hospital of Philadelphia, Philadelphia

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER